|
secondary endpoints
|
2
|
Resverlogix Corp.
|
Oct 30, 2019 06:46AM
|
|
run up
|
5
|
Resverlogix Corp.
|
Sep 26, 2019 07:48PM
|
|
RSI drop from 84 to 60
|
3
|
Resverlogix Corp.
|
Aug 10, 2018 10:08AM
|
|
reverse split
|
|
Resverlogix Corp.
|
Sep 12, 2018 06:13PM
|
|
Re: ZHCLF trading in registered accounts
|
1
|
Zenith Epigenetics
|
Feb 08, 2021 08:56PM
|
|
Re: ZHCLF trading
|
1
|
Zenith Epigenetics
|
Feb 05, 2021 03:07PM
|
|
Re: ZHCLF trading
|
1
|
Zenith Epigenetics
|
Feb 05, 2021 04:35PM
|
|
Re: ZHCLF trades on the OTC
|
3
|
Zenith Epigenetics
|
Jan 20, 2021 09:52AM
|
|
Re: Zenith_AGM_2018_09_1... (rough)
|
4
|
Zenith Epigenetics
|
Sep 22, 2018 10:56AM
|
|
Re: Zenith News
|
1
|
Zenith Epigenetics
|
Aug 27, 2020 08:12AM
|
|
Re: Zenith News
|
5
|
Zenith Epigenetics
|
May 05, 2020 05:35PM
|
|
Re: Zenith MD&A and Financials are up
|
|
Zenith Epigenetics
|
Sep 17, 2019 11:46AM
|
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 09:50AM
|
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
1
|
Zenith Epigenetics
|
Oct 05, 2020 06:27PM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
4
|
Zenith Epigenetics
|
Nov 20, 2018 02:59PM
|
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
3
|
Zenith Epigenetics
|
Aug 06, 2019 05:31PM
|
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 06, 2019 09:11AM
|
|
Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.
|
1
|
Zenith Epigenetics
|
Nov 17, 2021 05:33PM
|
|
Re: Zenith AGM? Trodelvy valuation comparison
|
5
|
Zenith Epigenetics
|
Dec 23, 2020 10:43AM
|
|
Re: Zenith AGM?
|
6
|
Zenith Epigenetics
|
Dec 23, 2020 10:48AM
|
